Accessibility links

Breaking News

Amid Conflicting Reports, Fate Of Ailing Uzbek President Remains Unclear


Uzbek President Islam Karimov (file photo)
Uzbek President Islam Karimov (file photo)

The fate of Uzbek President Islam Karimov remained uncertain on August 30, with no official word on his condition two days after the government announced he had been hospitalized for an undisclosed ailment.

There were conflicting reports, with the Fergana News Agency citing unnamed sources as saying that he had died and other media outlets, including Russian news agency Interfax, reporting that he was still alive.

READ MORE: Who Would Replace Karimov?

Russian President Vladimir Putin's spokesman, Dmitry Peskov, said on August 30 that the Kremlin had "no new information" and that it would be inappropriate for Moscow to comment on the Uzbek president's health.

The government statement on August 28 said Karimov, 78, would "require a certain amount of time for medical assessment and treatment."

Karimov's younger daughter, Lola Karimova-Tillyaeva, said in an Instagram post on August 29 that he was in "stable condition" at an intensive care unit in Tashkent after suffering a brain hemorrhage.

INFOGRAPHIC: How Does Karimov's Tenure Compare With Other Leaders?


Karimov had been scheduled to make a public appearance in Tashkent on September 1 during celebrations marking the 25th anniversary of Uzbekistan's independence.

He has ruled Uzbekistan since before the Soviet collapse of 1991.

His long rule and tight control have raised questions about succession and long-term stability in the Central Asian country of 28 million, which has never held an election judged free and fair by international monitors.

With reporting by Reuters, AP, AFP, Gazeta.uk, Fergana, and TASS
  • 16x9 Image

    RFE/RL

    RFE/RL journalists report the news in 27 languages in 23 countries where a free press is banned by the government or not fully established. We provide what many people cannot get locally: uncensored news, responsible discussion, and open debate.

XS
SM
MD
LG